海南海药：注射用美罗培南通过仿制药质量和疗效一致性评价

Core Viewpoint - Hainan Haiyao's subsidiary has received approval for the injectable antibiotic Meropenem, which is a broad-spectrum carbapenem antibiotic effective against various bacterial infections [1] Group 1: Company Information - Hainan Haiyao's subsidiary, Haikou Pharmaceutical Factory Co., Ltd., has been granted a drug supplement approval notice by the National Medical Products Administration for injectable Meropenem [1] - Meropenem is a synthetic broad-spectrum carbapenem antibiotic that inhibits bacterial cell wall synthesis, making it effective against a wide range of Gram-positive and Gram-negative bacteria [1] Group 2: Product Details - Meropenem is particularly stable against most beta-lactamases, including those produced by both Gram-positive and Gram-negative bacteria, except for metal beta-lactamases [1] - The injectable form of Meropenem is indicated for infections caused by single or multiple bacteria sensitive to Meropenem, including pneumonia, urinary tract infections, intra-abdominal infections, gynecological infections, skin and soft tissue infections, meningitis, and sepsis [1]